Kopran Ltd. Share Price

Overview

Kopran Ltd. share price is currently ₹280.86, up by ₹20.21 (7.75%) from its previous closing price of ₹260.65. The share price has gained 21.5% over the past month and gained 62.2% over the past year. The stock's 52-week low and high are ₹105.65 and ₹290.40, respectively. Kopran Ltd. has a market capitalisation of ₹ 1,210.00 Cr. The share price was last updated on 14 Oct 2026, 03:57 PM IST.

Kopran Ltd.
Kopran Ltd.
KOPRAN
 ₹0.00
 ₹20.21
7.75%
Healthcare
 ₹0.00(%)1D

Updated: 14 Oct 2026, 03:57:45 pm IST

Market Data

Open Price

 ₹275.15

Prev. Close

 ₹260.65
 ₹274.85

Day Low

 ₹281.94

Day High

 ₹105.65

52 Week Low

 ₹290.40

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMicro Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

54.32

Sector PE

42.81

PB Ratio

2.56

Sector PB

5.66

EPS

5.17

Dividend Yield

2.78

Today's Volume

949.240 K

5 Day Avg. Volume

546.897 K

PEG Ratio

-1.63

Market Cap.

₹ 1,210.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 30% at ₹3/Share
11-Aug-202611-Aug-2026
DividendsFinal Dividend of 30% at ₹3/Share
04-Sep-202504-Sep-2025
DividendsFinal Dividend of 30% at ₹3/Share
02-Sep-202403-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Motilal Oswal BSE Healthcare ETF742
753
(1.48%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth348
355
(2.01%)

About Kopran Ltd. 👋

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Power Of Finance (SEBI RA)

Power Of Finance (SEBI RA)

10 Apr • 4:29 PM · SEBI-Registered Analyst

Kopran Limited Responds to BSE Inquiries on Trading Activity, Confirms Compliance

KOPRAN
Kopran Limited has addressed dual BSE surveillance inquiries regarding unusual trading patterns in its scrip within two days. The company responded to volume movement inquiry on April 08, 2026, and price movement inquiry on April 10, 2026, consistently maintaining that all activities are market-driven and confirming full compliance with SEBI disclosure regulations.

See More
AASHISH RA

AASHISH RA

23 Dec • 6:54 PM · SEBI-Registered Analyst

Kopran Ltd (KORPRAN) – SWOT Analysis

KOPRAN
Strengths Established Pharma Player: Long-standing presence in APIs and formulations. Domestic & Export Markets: Products supplied in India and select international markets. Integrated Operations: API manufacturing supports formulation business. Cost-Efficient Manufacturing: Plants located in cost-effective regions. Brand Presence: Recognized brands in select therapeutic segments. Weaknesses Limited Scale: Smaller compared to large pharmaceutical peers. Product Concentration: Dependence on a limited number of molecules. Margin Pressure: Pricing pressure in generics and APIs. Low R&D Intensity: Limited investment in new molecule development. Liquidity Constraints: Lower market liquidity and investor coverage. Opportunities Generic Drug Demand: Continued growth in affordable healthcare. API Self-Reliance Push: Government support for domestic API manufacturing. Export Expansion: Opportunity to enter semi-regulated markets. New Product Launches: Addition of formulations in chronic therapies. Contract Manufacturing: Scope for partnerships and CDMO opportunities. Threats Regulatory Risks: Stringent compliance requirements from drug regulators. Competition: Intense competition from domestic and global generic players. Raw Material Volatility: Dependence on imported intermediates. Price Controls: Government price caps under DPCO. Forex Risk: Currency fluctuations affecting exports. Disclaimer Disclaimer: This content is shared only for educational and informational purposes and should not be considered as investment advice or a recommendation to buy, sell, or hold any security. Stock market investments are subject to market risks. Please consult a SEBI-registered investment advisor before making any investment decisions. Registration Number: INH000013174

See More
Sohrab Shaikh (SEBI RA)

Sohrab Shaikh (SEBI RA)

1 Sep • 7:02 PM · SEBI-Registered Analyst

Ex-Dividend date on 02-09-2024

1. Accent Microcell Rs. 0.1 per share 2. CG VAK Software Rs. 1 per share 3. Delaplex Rs. 2.75 per share 4. Dynamic Industries Rs. 0.5 per share 5. Kopran Rs. 3 per share 6. Kovilpatti Lakshi Roller Flour Mills Rs. 1.25 per share 7. Krystal Integrated Services Rs. 1.5 per share 8. Lancor Holding Rs. 0.2 per share 9. Sanco Tans Rs. 1.5 per share

See More
Mayank Kumar

Mayank Kumar

8 Aug • 8:30 AM · SEBI-Registered Analyst

Results

Abb India, Ajmera Realty & Infra India, Alicon Castalloy, Amines & Plasticizers, Alembic Pharmaceuticals, Artemis Medicare Services, Astral, Astrazeneca Pharma, Avalon Technologies, Antony Waste Handling Cell, Azad Engineering, Bajel Projects, Bayer Cropscience, Bombay Burmah Trading Corp, Bharat Forge, Biocon, Birla Corporation, Balmer Lawrie Investments, Bharat Parenterals, Carysil, Chemfab Alkalis, Cheviot Co, Cochin Shipyard, Concor, Cosmo First, Digispice Technologies, Dreamfolks Services, Eicher Motors, Essar Shipping, Filatex India, Galaxy Surfactants, Garware Technical Fibres, Gateway Distriparks, Gretex Corporate Services, Geecee Ventures, Greaves Cotton, Garden Reach Shipbuilders & Engineers, Garware Hi-Tech Films, Gujarat State Petronet, Gujarat Alkalies & Chemicals, Hbl Power Systems, Healthcare Global Enterprises, Hcl Infosystems, Ifci, Igarashi Motors India, Indian Hume Pipe Co, India Shelter Finance Corporation, Indo Amines, Inspirisys Solutions, Ircon International, Iris Business Services, ***** & Pharma, Khadim India, Kilitch Drugs (India), Kilburn Engineering, Kopran, Life Insurance Corp, Lincoln Pharma, Lumax Industries, Mayur Uniquoters, Global Health, Minda Corporation, Mindteck (India), Media Matrix Worldwide, Moneyboxx Finance, Mps, Mrf, Munjal Auto Industries, Nava, Ndr Auto Components, The New India Assurance Co, Nikhil Adhesives, Nocil, Oil India, Orient Paper & Industries, Page Industries, Pcbl, Peninsula Land, Prevest Denpro, RK Swamy, Rvnl, Sail, Sandhar Technologies, Sansera Engineering, Shalimar Paints, Shankara Building Products, Shilpa Medicare, Shreyas Shipping & Logistics, Snowman Logistics, Sobha, State Trading Corporation Of India, Steelcast, Sutlej Textiles & Industries, Tcc Concept, Tega Industries, Timken India, Transpek Industry, Tvs Holdings, Uni Abex Alloy Products, Unichem Laboratories, Uniparts India, Va Tech Wabag.

See More

News & Events

Frequently Asked Questions

What is the share price of Kopran Ltd.?

What is the market cap of Kopran Ltd.?

Should I buy Kopran Ltd. stock now?

What is the 52 week high and low of Kopran Ltd.?

Is the Kopran Ltd. stock good to buy?

Is Kopran Ltd. a good buy for the long term?

Is Kopran Ltd. overvalued or undervalued?

What is the PE and PB ratio of Kopran Ltd.?

Begin your investment journey today
Login/Register
What's Moving?

Today's market leaders and laggards

Sejal Glass Ltd.

Sejal Glass Ltd.

SEJALLTD

₹865.76

+149.49 (20.87%)

MV Electrosystems Ltd.

MV Electrosystems Ltd.

MVELECTRO

₹968.52

+150.82 (18.44%)

Transformers & Rectifiers (India) Ltd.

Transformers & Rectifiers (India) Ltd.

TARIL

₹345.91

+47.02 (15.73%)

CKK Retail Mart Ltd.

CKK Retail Mart Ltd.

CKKRETAIL

₹182.77

+24.28 (15.32%)

West Coast Paper Mills Ltd.

West Coast Paper Mills Ltd.

WSTCSTPAPR

₹927.69

+115.13 (14.17%)

Today's top moversExplore all →
Start Now